arrow
J

Jaspreet Singh Grewal

university of warwick
H指数:13
被引数:942

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

In Situ Lipid Interactions of an Anticancer Metal Complex

原位脂质相互作用:一种抗癌金属配合物

2026-03-130
OA
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation

Garsorasib,一种KRAS G12C抑制剂,有或没有西妥昔单抗,一种EGFR抗体,在患有KRAS G12C突变的晚期实体瘤的II期临床试验的结直肠癌队列中

2025-06-170
OA
Phase II trial of ozuriftamab vedotin (BA3021), a conditionally active biologic (CAB)-ROR2-ADC, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)

奥兹里夫单抗vedotin(BA3021)的II期临床试验,该药是一种条件性活性生物制剂(CAB)-ROR2-抗体药物偶联物(ADC),用于复发或转移性头颈鳞状细胞癌(R/M SCCHN)患者。

2024-09-012
PRE
Pharmacokinetics and pharmacodynamics of IGM-8444, a first-in-class engineered pentameric DR5-targeting agonist IgM monoclonal antibody, in patients with R/R and newly diagnosed cancers
2023-12-010
PRE
A randomized Phase 1b study of IGM-8444 in combination with FOLFIRI plus bevacizumab compared to FOLFIRI plus bevacizumab alone in second line metastatic colorectal cancer
2023-12-011
PRE